Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Firy Inc. (FIRY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Firy Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Firy Inc. trades at $10.01 (market cap $159.51M), while State Street SPDR S&P Biotech ETF trades at $159.75. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals.

FIRYXBI
Market Cap
$159.51M
Sector
Consumer CyclicalBroad Market / Factor
52-Week High
$12.45$164.28
52-Week Low
$2.28$86.92
Enterprise Value
$103.18M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Firy Inc.

FIRY trades at $10.48, up 0.29% today, with a bullish technical outlook from moving averages. The company shows improving revenue trends ($104.5M in 2025) but continues to report significant losses (-$70.41M net income). Recent developments include a $719 million legal victory and corporate rebranding from Skillz Inc. Analyst sentiment remains mixed with a 60% hold rating.

The stock presents speculative potential from legal wins and revenue stabilization, but persistent negative margins and cash burn (-$86.41M net cash flow) pose substantial risks. Upside depends on achieving profitability, while downside risk remains elevated from ongoing operational losses.

State Street SPDR S&P Biotech ETF

XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.

Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.

Returns comparison

Trailing returns across standard periods

About Firy Inc.

Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.

Read more on FIRY

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI